| scholarly article | Q13442814 |
| P50 | author | Kristiina Aittomäki | Q29840622 |
| Heli Nevanlinna | Q29840669 | ||
| Carl Blomqvist | Q73625505 | ||
| Anna Nurmi | Q87776664 | ||
| Ralf Bützow | Q96173098 | ||
| Johanna I Kiiski | Q114337491 | ||
| Sini Lehto | Q114337590 | ||
| Taru A. Muranen | Q37371838 | ||
| Anne Kallioniemi | Q40045978 | ||
| Johanna Schleutker | Q42590313 | ||
| Liisa Pelttari | Q43176891 | ||
| Tuomas Heikkinen | Q56204849 | ||
| P2860 | cites work | Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 |
| Germline mutations in RAD51D confer susceptibility to ovarian cancer | Q28245028 | ||
| Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
| A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer | Q33663091 | ||
| Distribution and medical impact of loss-of-function variants in the Finnish founder population | Q33981677 | ||
| Gene-gene interactions in breast cancer susceptibility | Q34017597 | ||
| A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes | Q34115258 | ||
| Breast-cancer risk in families with mutations in PALB2 | Q34148873 | ||
| Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction | Q34394665 | ||
| Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer | Q34408752 | ||
| Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility | Q35906993 | ||
| FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor | Q35999309 | ||
| Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
| CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer | Q36449203 | ||
| Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing | Q58797082 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls | Q37048943 | ||
| A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer | Q37218535 | ||
| Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer | Q37373918 | ||
| Genetic modifiers of CHEK2*1100delC-associated breast cancer risk | Q37739048 | ||
| Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication | Q38627916 | ||
| Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 | ||
| Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer | Q39053021 | ||
| Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers | Q39437211 | ||
| Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene | Q40053289 | ||
| Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks | Q40094101 | ||
| FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population | Q42683589 | ||
| ATM mutations in Finnish breast cancer patients | Q43074862 | ||
| BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients | Q44969666 | ||
| Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients | Q45097069 | ||
| Association analysis identifies 65 new breast cancer risk loci. | Q45979098 | ||
| The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype | Q46041916 | ||
| Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations | Q46168959 | ||
| NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer | Q46567991 | ||
| Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer | Q46782579 | ||
| Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. | Q47828874 | ||
| Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families. | Q48288066 | ||
| Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. | Q48526678 | ||
| Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. | Q51421155 | ||
| Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer. | Q51773668 | ||
| Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations. | Q53316752 | ||
| A recurrent mutation in PALB2 in Finnish cancer families. | Q55043120 | ||
| Germline RAD51C mutations confer susceptibility to ovarian cancer | Q57266552 | ||
| Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients | Q57274822 | ||
| Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes | Q57274836 | ||
| RAD51C is a susceptibility gene for ovarian cancer | Q57306209 | ||
| BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families | Q57306231 | ||
| Familial breast cancer in southern Finland | Q57306234 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2692-2700 | |
| P577 | publication date | 2019-04-25 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients | |
| P478 | volume | 145 |
| Q90267561 | ALTernative Functions for Human FANCM at Telomeres | cites work | P2860 |
Search more.